Interaction of C60-fullerene and carboxyfullerene with proteins:: Docking and binding site alignment

被引:106
作者
Benyamini, H
Shulman-Peleg, A
Wolfson, HJ
Belgorodsky, B
Fadeev, L
Gozin, M
机构
[1] Tel Aviv Univ, George S Wise Fac Life Sci, Bioinformt Unit, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Beverly & Raymond Sackler Fac Exact Sci, Sch Comp Sci, IL-69978 Tel Aviv, Israel
关键词
D O I
10.1021/bc050299g
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The unique properties of fullerenes have raised the interest of using them for biomedical applications. Within this framework, the interactions of fullerenes with proteins have been an exciting research target, yet little is known about how native proteins can bind fullerenes, and what is the nature of these interactions. Moreover, though some proteins have been shown to interact with fullerenes, up to date, no crystal structure of such complexes was obtained. Here we report docking studies aimed at examining the interactions of fullerene in two forms (C-60 nonsubstituted fullerene and carboxyfullerene) with four proteins that are known to bind fullerene derivatives: HIV protease, fullerene-specific antibody, human serum albumin, and bovine serum albumin. Our work provides docking models with detailed binding pockets information, which closely match available experimental data. We further compare the predicted binding sites using a novel multiple binding site alignment method. A high similarity between the physicochemical properties and surface geometry was found for fullerene's binding sites of HIV protease and the human and bovine serum albumins.
引用
收藏
页码:378 / 386
页数:9
相关论文
共 45 条
[11]  
Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185
[12]   Optimizing the binding of fullerene inhibitors of the HIV-1 protease through predicted increases in hydrophobic desolvation [J].
Friedman, SH ;
Ganapathi, PS ;
Rubin, Y ;
Kenyon, GL .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (13) :2424-2429
[13]   INHIBITION OF THE HIV-1 PROTEASE BY FULLERENE DERIVATIVES - MODEL-BUILDING STUDIES AND EXPERIMENTAL-VERIFICATION [J].
FRIEDMAN, SH ;
DECAMP, DL ;
SIJBESMA, RP ;
SRDANOV, G ;
WUDL, F ;
KENYON, GL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (15) :6506-6509
[14]   Identification of the N-terminal peptide binding site of glucose-regulated protein 94 [J].
Gidalevitz, T ;
Biswas, C ;
Ding, H ;
Schneidman-Duhovny, D ;
Wolfson, HJ ;
Stevens, F ;
Radford, S ;
Argon, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (16) :16543-16552
[15]   DALI - A NETWORK TOOL FOR PROTEIN-STRUCTURE COMPARISON [J].
HOLM, L ;
SANDER, C .
TRENDS IN BIOCHEMICAL SCIENCES, 1995, 20 (11) :478-480
[16]   Blockage of apoptotic signaling of transforming growth factor-β in human hepatoma cells by carboxyfullerene [J].
Huang, YL ;
Shen, CKF ;
Luh, TY ;
Yang, HC ;
Hwang, KC ;
Chou, CK .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 254 (01) :38-43
[17]   Approaching the CAPRI challenge with an efficient geometry-based docking [J].
Inbar, Y ;
Schneidman-Duhovny, D ;
Halperin, I ;
Oron, A ;
Nussinov, R ;
Wolfson, HJ .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2005, 60 (02) :217-223
[18]  
Jin H, 2000, J NEUROSCI RES, V62, P600, DOI 10.1002/1097-4547(20001115)62:4<600::AID-JNR15>3.0.CO
[19]  
2-F
[20]   Fullerene inhibits β-amyloid peptide aggregation [J].
Kim, JE ;
Lee, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 303 (02) :576-579